Of all the eye research developments reported on the VisionAware blog, it is stem cell research for eye disease that generates the most inquiries from readers. Many readers request information about how to join a stem cell clinical trial, or find a doctor who will perform stem cell treatments. In response to these inquiries, my … Continued
Guest blogger Bryan Gerritsen is a certified low vision therapist (CLVT) and owner of Low Vision Rehabilitation Services, providing low vision services throughout Utah. He is also the author of An Overview of Low Vision Devices, What are Low Vision Optical Devices?, Helpful Non-Optical Devices for Low Vision, Electronic Magnifiers and Magnifying Systems, and the … Continued
Guest blogger Bryan Gerritsen is a certified low vision therapist (CLVT) and owner of Low Vision Rehabilitation Services, providing low vision services throughout Utah. He is also the author of An Overview of Low Vision Devices, What are Low Vision Optical Devices?, Helpful Non-Optical Devices for Low Vision, Electronic Magnifiers and Magnifying Systems, and the … Continued
Irv Arons is the creator of – and driving force behind – Irv Arons’ Journal, an online compendium of the latest information on ophthalmics, medical lasers, clinical trials, developments in stem cell therapy and gene therapy, and emerging drug therapies and treatments for retinal diseases, including age-related macular degeneration. Until his retirement in 2005, Irv … Continued
Please note: This is an older post and there have been setbacks and significant changes in stem cell research for eye disease since this was first published. For more current information, see Our Readers Want to Know: What Is the Progress of Stem Cell Research for Eye Disease? Answer: It Has a Very Long Way … Continued
A joint China-United States research team has discovered that a class of stem cells derived from an individual’s own cells were not rejected by the immune system when they were turned into retinal pigment epithelium cells destined for the eye. This important discovery provides a boost for the development of human stem cell therapies to … Continued
A research group of Swiss and German scientists has restored vision to mice with a condition similar to retinitis pigmentosa (RP) by introducing engineered light-sensing proteins into their eyes, via a process known as optogenetics. Optogenetics is a still-experimental treatment for a variety of blinding retinal disorders that uses gene therapy to enable retinal and … Continued
Please note: this is an older post and much has changed since the time of publication. For more current information, see Our Readers Want to Know: What Is the Progress of Stem Cell Research for Eye Disease? Answer: It Has a Very Long Way to Go. Also see the author’s updates, below. On October 14, … Continued
During Vision Research Month, it gives me great pleasure to highlight the work of the Vision Institute of Paris and its subsidiary StreetLab. Both organizations are committed to ongoing vision research, with StreetLab featuring complementary and innovative outreach methods to enhance accessibility, inclusion, public awareness, and education. The Vision Institute of Paris (L’Institut de la … Continued
Since November 2010, I have been following Advanced Cell Technology’s (ACT) quest to implement successful clinical trials for macular eye disease, using human embryonic stem cells. ACT’s U.S. and European Phase I/II clinical trials each involve a total of 12 patients, in groups of three (also called cohorts). The first group/cohort received a dosage of … Continued